Roivant Sciences Ltd (ROIV)

03:04 AM

10 Best Biotech Stocks to Buy According to Billionaire Steve Cohen - Insider Monkey

03:04 AM

10:41 AM

What drives Roivant Sciences Ltd. stock priceExceptional risk-adjusted gains - jammulinksnews.com

10:41 AM

01:43 AM

What analysts say about Roivant Sciences Ltd. stockTriple-digit profit margins - jammulinksnews.com

01:43 AM

Jul 22, 2025

Roivant Sciences Ltd. Stock Analysis and ForecastAccelerated wealth building - jammulinksnews.com

Jul 22, 2025

Jul 19, 2025

Is Roivant Sciences Ltd. a good long term investmentFree Stock Selection - jammulinksnews.com

Jul 19, 2025

Jul 18, 2025

(ROIV) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 18, 2025

Jul 10, 2025

Goldman Sachs resumes Roivant Sciences stock coverage with Buy rating By Investing.com - Investing.com South Africa

Jul 10, 2025

Jul 10, 2025

Goldman Sachs resumes Roivant Sciences stock coverage with Buy rating - Investing.com India

Jul 10, 2025

Jul 07, 2025

How to Take Advantage of moves in (ROIV) - news.stocktradersdaily.com

Jul 07, 2025

Jul 05, 2025

Roivant Sciences: Booming Pipeline Without Product Revenues Creates Valuation Riddle - Seeking Alpha

Jul 05, 2025

Jun 26, 2025

'Just the beginning': Vivek Ramaswamy breaks record in raising fund for Guv election campaign, $8.5 milli - Times of India

Jun 26, 2025

Jun 25, 2025

Hedge Fund and Insider Trading News: Ken Griffin, Warren Buffett, Michael Burry, AQR Capital Management, Tiger Global Management, Amplify Energy Corp (AMPY), Roivant Sciences ltd (ROIV), and More - Insider Monkey

Jun 25, 2025

Jun 24, 2025

Roivant Sciences Announces $500M Share Repurchase Program - TipRanks

Jun 24, 2025

Jun 23, 2025

Roivant Sciences (ROIV): Ramaswamy sells $13 million in shares - Investing.com

Jun 23, 2025

Jun 18, 2025

HC Wainwright & Co. Reiterates Buy Rating for Roivant Sciences (ROIV) | ROIV Stock News - GuruFocus

Jun 18, 2025

Jun 18, 2025

Cantor Fitzgerald reiterates overweight rating on Roivant Sciences stock By Investing.com - Investing.com India

Jun 18, 2025

Jun 18, 2025

H.C. Wainwright reiterates buy rating on Roivant Sciences stock By Investing.com - Investing.com India

Jun 18, 2025

Jun 18, 2025

Guggenheim maintains buy rating on Roivant Sciences stock amid DM study - Investing.com India

Jun 18, 2025

Jun 18, 2025

JPMorgan Maintains Positive Outlook on Roivant Sciences (ROIV) | ROIV Stock News - GuruFocus

Jun 18, 2025

Jun 17, 2025

Roivant (ROIV) Hosts Investor Webinar on Brepocitinib's Role in Dermatomyositis | ROIV Stock News - GuruFocus

Jun 17, 2025

Jun 16, 2025

Long Term Trading Analysis for (ROIV) - news.stocktradersdaily.com

Jun 16, 2025

Jun 16, 2025

Roivant (ROIV) Publishes Promising Phase 1 Results for Inhaled M - GuruFocus

Jun 16, 2025

Jun 10, 2025

Roivant Sciences at Goldman Sachs Conference: Strategic Execution Focus By Investing.com - Investing.com South Africa

Jun 10, 2025

Jun 10, 2025

Roivant Sciences at Goldman Sachs Conference: Strategic Execution Focus - Investing.com Australia

Jun 10, 2025

Jun 09, 2025

Roivant and Priovant to Host Investor Video Conference at 1:00 PM ET on Tuesday, June 17 on Brepocitinib and the Unmet Medical Need in Dermatomyositis - Yahoo Finance

Jun 09, 2025

Jun 09, 2025

Rare Disease Breakthrough: Roivant Reveals Brepocitinib Data for Dermatomyositis Treatment - Stock Titan

Jun 09, 2025

Jun 07, 2025

Major Shareholder Cashes Out Millions in Roivant Sciences Stock - TipRanks

Jun 07, 2025

Jun 04, 2025

(ROIV) Trading Advice - news.stocktradersdaily.com

Jun 04, 2025

May 31, 2025

Vivek Ramaswamy’s firm wants to buy biotech companies to bet on bitcoin - MSN

May 31, 2025

May 31, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $324,000 Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - Defense World

May 31, 2025

May 31, 2025

Roivant Sciences Earnings Call: Balancing Growth and Challenges - MSN

May 31, 2025

May 30, 2025

Roivant outlines packed 36-month launch and data cycle with under $5B cash reserve and multi-blockbuster pipeline - MSN

May 30, 2025

May 30, 2025

Decoding Roivant Sciences Ltd (ROIV): A Strategic SWOT Insight - GuruFocus

May 30, 2025

May 30, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2024 Earnings Call Transcript - Insider Monkey

May 30, 2025

May 30, 2025

Roivant Sciences Full Year 2025 Earnings: EPS Beats Expectations, Revenues Lag - simplywall.st

May 30, 2025

May 30, 2025

While Wall Street Naps, These 10 Stocks Run Wild - Insider Monkey

May 30, 2025

May 30, 2025

Why Roivant Sciences Ltd. (ROIV) Surged On Thursday - Insider Monkey

May 30, 2025

May 30, 2025

Roivant Sciences Ltd (ROIV) Q4 2024 Earnings Call Highlights: Strong Financial Position and ... By GuruFocus - Investing.com Canada

May 30, 2025

May 30, 2025

Roivant Sciences Reports Progress and Financial Results - TipRanks

May 30, 2025

May 29, 2025

IMVT INVESTIGATION ALERT: Investigation Launched into Private Placement Transaction by Immunovant, Inc. and Attorneys Encourage Investors to Contact Law Firm - The Malaysian Reserve

May 29, 2025

May 29, 2025

Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Lags Revenue Estimates - MSN

May 29, 2025

May 29, 2025

IMVT INVESTIGATION ALERT: Investigation Launched into Private Placement Transaction by Immunovant, Inc. and Attorneys Encourage Investors to Contact Law Firm – Company AnnouncementFT.com - Financial Times

May 29, 2025

May 29, 2025

ROIV Crosses Above Key Moving Average Level - Nasdaq

May 29, 2025

May 29, 2025

Roivant Sciences earnings missed by $0.03, revenue fell short of estimates - Investing.com South Africa

May 29, 2025

May 29, 2025

Roivant Sciences Q4 2025 Earnings Call Transcript - MarketBeat

May 29, 2025

May 29, 2025

Roivant Sciences (ROIV) Stock Jumps Nearly 5%: What’s Fueling This Biotech Rally? - Daily Chhattisgarh News

May 29, 2025

May 29, 2025

Roivant Sciences Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 - marketscreener.com

May 29, 2025